This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 23-26, 2024
Hynes Convention Center in BostonBoston, MA
September 23-26, 2024|Hynes Convention Center in Boston, Boston, MA

THE LARGEST BIOPROCESSING EVENT FOR LEARNING HOW TO ACCELERATE PROMISING BIOLOGICS, CELL & GENE THERAPIES TOWARDS COMMERCIAL SUCCESS

Access the science, technologies and contacts you need to improve efficiencies across all phases of biopharmaceutical development and production.

3000+ Global Attendees · 250+ Exhibitors · 180+ Scientific Posters · 8 Conference Tracks

Thank You to the 3000+ Attendees of BioProcess International 2023!

Last year's event was the largest in event history, gathering 3000+ attendees and 260+ exhibitors representing 40 countries around the world. The full scientific agenda and attendee registration for BPI 2024 will open soon. While you wait, be sure to check out our upcoming BPI events in 2024:

Access Scientific Innovation at BioProcess International

Each year, more than 3000+ bioprocessing professionals representing 40+ countries attend BioProcess International in Boston to learn about today's innovative science across the entire spectrum of biopharmaceutical development and production.

Our exhibition featured 260+ exhibitors showcasing novel technologies designed to accelerate biologics from process development through to commercial manufacturing.

Access Novel Science Across the Entire Bioprocessing Spectrum

Our BPI 2024 agenda includes 9 conference tracks covering novel science across all phases of bioprocessing for biologics, cell & gene therapies.  Your registration provides access to the presentations across all 8 tracks, allowing you to create an agenda tailored specifically for your needs.  Your conference pass provides on-demand access to the main conference presentation recordings for a full 12 months after the in-person event concludes.

NEW for 2024! Cell Line Development & Engineering

Advance your mAbs and beyond by enhancing your cell lines. Increase productivity, stability and yield through the latest technologies surrounding automation and data management, systems & synthetic biology and cell monitoring.   

NEW for 2024! Development of Emerging CGTs

Explore the development of cutting-edge modalities, approaches, and strategies; to help you overcome roadblocks during clinical development and reach commercial stage manufacturing at an expedited pace. 

Cell Culture & Upstream Processing

Maximize productivity and quality for your future pipeline utilizing automation, perfusion and media development all whilst reducing COGs.  

Recovery & Purification

Leverage predictive approaches, prior knowledge, digital applications and data while applying transformative technologies to overcome bottlenecks, maximize quality and control, and enable next generation downstream processing for emerging modalities.

Analytical & Quality

Achieve a high-quality product using optimal analytical strategies, PAT and process development whilst reducing timelines.

Manufacturing Strategy & Bioprocessing 4.0

Understand strategic approaches for cost-effective and scalable commercial manufacturing of biologics. Utilize cutting edge technologies to accelerate timelines, boost efficiency and improve sustainability of processes. 

Cell Therapy Manufacturing

Improve productivity, efficiency, analytical characterization and reduce cost of goods in the cell therapy manufacturing process for your products, with case study insights from Sanofi, Beam Therapeutics, and more…

Gene Therapy Manufacturing

Increase speed, consistency, and scalability to overcome manufacturing challenges during the development and commercialization of your in vivo and ‘off the shelf’ gene therapies, including learnings from Ultragenyx, Siren Biotechnology, and more…

Well Characterized Biologics & Biological Assays

Gain practical advice from case studies, FDA & regulatory leaders to accelerate your biologics & novel modalities/molecules to market.

Lars Pampel, Ph.D., Head, Process Sciences, Technical Development, New Biological Entities, Novartis, Switzerland

DataHow

“BPI brings leading thoughts and discussion to a balanced audience of scientists and decision makers.”

CONNECT WITH KEY BUYERS BY BECOMING A BPI SPONSOR/EXHIBITOR

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your sales and marketing goals. Contact us today at Partners@informaconnectls.com to discuss.